11 completed, 10 recruiting, 6 unknown, 5 active not recruiting. 6 Not applicable, 5 Phase 2, 4 Phase 3, 1 Phase 1.
Follow Interstitial Lung Diseases: new trials by email Literature Review of Interstitial Lung Diseases trials Research Report on Interstitial Lung Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression Nerandomilast, Placebo matching nerandomilast - Interstitial Lung Diseases | Phase 3 | Recruiting | Boehringer Ingelheim | 466 | 2026-09-17 | 2026-10-28 |
| Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease golidocitinib plus corticosteroid, non-JAK inhibitor immunosuppressant plus corticosteroid - Interstitial Lung Diseases | Phase 2 | Not yet recruiting | Peking Union Medical College Hospital | 60 | 2026-09-01 | 2026-07-30 |
| A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis Nerandomilast, Placebo - Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities | Phase 3 | Recruiting | Boehringer Ingelheim | 80 | 2026-02-10 | 2026-10-28 |
| The Effects of Whole-Body Vibration Training on Clinical and Functional Outcomes in Individuals Diagnosed With Interstitial Lung Disease Inspiratory Muscle Training, Peripheral Muscle Strengthening Exercises, Aerobic Exercise Training (Cycle Ergometer) - Interstitial Lung Diseases | Not applicable | Completed | Istinye University | 26 | 2026-01-15 | 2026-07-17 |
| Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases bronchoscopy - Interstitial Lung Diseases | Not yet recruiting | Maha Ahmed Abd EL Gawad Mohammed Okasha | 66 | 2025-12-04 | 2025-10-06 | |
| Home-based Pulmonary Rehabilitation in Interstitial Lung Disease Home-based pulmonary rehabilitation, Standard-of-care treatment - Interstitial Lung Diseases | Not applicable | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 80 | 2025-11-01 | 2026-10-05 |
| Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis there is no intervention - Lung Cancer (Diagnosis), Pulmonary Fibrosis | Active not recruiting | The First Affiliated Hospital with Nanjing Medical University | 200 | 2025-11-01 | 2026-03-17 | |
| A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases Nerandomilast, Placebo matching nerandomilast - Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases | Phase 3 | Active not recruiting | Boehringer Ingelheim | 414 | 2025-09-13 | 2026-10-28 |
| Interstitial Lung Diseases in Respiratory ICU Interstitial Lung Diseases | Not yet recruiting | Sohag University | 50 | 2025-08-01 | 2025-08-12 | |
| A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis Ofev® - Interstitial Lung Diseases, Systemic Sclerosis Associated Interstitial Lung Disease | Active not recruiting | Boehringer Ingelheim | 2000 | 2025-06-17 | 2025-12-08 | |
| Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis Photon counting CT - IPF, ILD | Recruiting | Istituto Clinico Humanitas | 156 | 2025-03-25 | 2026-08-27 | |
| Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases Interstitial Lung Diseases | Recruiting | IRCCS San Raffaele | 123 | 2024-09-01 | 2026-01-15 | |
| RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis CABA-201 - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Recruiting | Cabaletta Bio | 37 | 2024-07-02 | 2026-10-16 |
| LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease Interstitial Lung Diseases | Recruiting | Aveiro University | 150 | 2024-04-01 | 2024-04-30 | |
| Ultrasound and Respiratory Physiological Signals in Lung Diseases Lung ultrasound, computed tomographic scan and patch-based cardio-respiratory evaluations - Interstitial Lung Disease, Interstitial Lung Diseases | Not applicable | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 25 | 2023-03-22 | 2026-05-20 |
| Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases Breath test using the Compact PTR-TOF-MS, Portable cardiac monitor "CardioQvark", Assessment of arterial stiffness using the VaSera VS-1500N - Chronic Respiratory Diseases, Cystic Fibrosis | Enrolling by invitation | I.M. Sechenov First Moscow State Medical University | 400 | 2023-01-30 | 2024-07-30 | |
| Monitoring and Evaluation Study of Project ECHO for ILD Interstitial Lung Diseases | Unknown | Pulmonary Care and Research Collaborative Limited | 200 | 2022-07-01 | 2022-07-13 | |
| Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives Interstitial Lung Diseases | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 3000 | 2022-01-19 | 2026-02-12 | |
| Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease Hyperpolarized 129Xe - Interstitial Lung Diseases | Phase 2 | Completed | Bastiaan Driehuys | 47 | 2021-11-12 | 2026-08-05 |
| Anlotinib Capsules in the Treatment for IPF/PF-ILDs Anlotinib, Placebo - Interstitial Lung Diseases | Phase 2 | Active not recruiting | First Affiliated Hospital of Wenzhou Medical University | 30 | 2021-09-28 | 2026-06-05 |
Showing 20 of 36. Sign in to see all of them.
Lung Diseases, Interstitial (36) · Idiopathic Pulmonary Fibrosis (7) · Pulmonary Disease, Chronic Obstructive (5) · Sarcoidosis (5) · Asthma (4) · Pulmonary Fibrosis (3) · Alveolitis, Extrinsic Allergic (2) · Disease (2) · Idiopathic Interstitial Pneumonias (2) · Inflammation (2) · Lung Neoplasms (2) · Scleroderma, Systemic (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Bronchiectasis (1)
Lung Diseases (36) · Respiratory Tract Diseases (36) · Immune System Diseases (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Hypersensitivity (9) · Hemic and Lymphatic Diseases (6) · Lung Diseases, Obstructive (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Pulmonary Fibrosis (6) · Chronic Disease (5) · Disease Attributes (5) · Hypersensitivity, Delayed (5) · Hypersensitivity, Immediate (5)
Adrenal Cortex Hormones (1) · BI 1015550 (1) · Blood Specimen Collection (1) · Bronchoscopy (1) · Observation (1) · Respiratory Physiological Phenomena (1) · Tomography, Optical Coherence (1) · Urine Specimen Collection (1) · anlotinib (1) · nintedanib (1)
Boehringer Ingelheim (4) · Maastricht University Medical Center (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Andreas Guenther (1) · Aveiro University (1) · Bastiaan Driehuys (1) · Cabaletta Bio (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · China-Japan Friendship Hospital (1) · Chonbuk National University (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Gabriela Riemekasten (1) · I.M. Sechenov First Moscow State Medical University (1) · IRCCS San Raffaele (1)
Italy (9) · China (8) · France (8) · Netherlands (7) · United States (7) · United Kingdom (6) · Germany (5) · South Korea (4) · Australia (3) · Austria (3) · Japan (3) · Spain (3) · Switzerland (3) · Argentina (2) · Belgium (2)
Aalt Bast, PhD (2) · Agnes W Boots, PhD (2) · Alda S. Marques, PhD (1) · Aliaa Barakat, PhD (1) · Andrea Smargiassi, MD, PhD (1) · Arnaud Bourdin, MD, PhD (1) · Christopher Denton, Prof. (1) · Fireman Lizy, PhD (1) · Francesco Amati, MD (1) · Gabriela Riemekasten, Prof. (1) · Guido R Haenen, PhD (1) · Huiping Li, MD,PhD (1) · J.C. Grutters, M.D. (1)
PMID 17448649, PMID 28720095, PMID 28775245, PMID 30055613, PMID 30742809, PMID 30823880, PMID 30864813, PMID 31319833, PMID 32325432, PMID 33209910, PMID 33717159, PMID 34564355, PMID 34606062, PMID 36541529, PMID 38460070, PMID 39558302, PMID 39879227, PMID 40967367, PMID 41673669, PMID 42681624
2023 (1), 2025 (1), R01HL126771 (1), R21AI126031 (1)